Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes
申请人:DermBiont, Inc.
公开号:US11040077B2
公开(公告)日:2021-06-22
Disclosed herein are compositions and methods for using human-derived Janthinobacterium lividum. Compositions improve skin health. Methods may include applying human-derived Janthinobacterium lividum over a host or host area, such as skin or mucosa, to minimize the presence of one or more microbes, maximize therapeutic effects, and/or improve health. A method to minimize a pathogenic microbe may include applying to a surface a composition including human-derived Janthinobacterium lividum and an acceptable carrier. Compositions and methods may include a prebiotic to maximize growth and/or metabolites. Compositions and methods may include human-derived Janthinobacterium lividum metabolites, such as violacein, prodigiosin, indole-3-carboxaldehyde, and lantibiotics, and/or other Postbiotics.
本文公开了使用源自人类的 Lividum Janthinobacterium 的组合物和方法。组合物可改善皮肤健康。方法可包括在宿主或宿主区域(如皮肤或粘膜)上施用源于人的生发的Lividum Janthinobacterium,以最大限度地减少一种或多种微生物的存在,最大限度地提高治疗效果,和/或改善健康状况。减少病原微生物的方法可包括向表面施用一种组合物,该组合物包括来源于人类的Janthinobacterium lividum和一种可接受的载体。组合物和方法可包括益生元,以最大限度地提高生长和/或代谢物。组合物和方法可包括来源于人的猪蓝细菌代谢物,如violacein、prodigiosin、吲哚-3-甲醛、兰特益生菌和/或其他后益生菌。